Literature DB >> 15623778

Quantifying effects of retinal illuminance on frequency doubling perimetry.

William H Swanson1, Mitchell W Dul, Susan E Fischer.   

Abstract

PURPOSE: To measure and quantify effects of variation in retinal illuminance on frequency doubling technology (FDT) perimetry.
METHODS: A Zeiss-Humphrey/Welch Allyn FDT perimeter was used with the threshold N-30 strategy. Study 1, quantifying adaptation: 11 eyes of 11 subjects (24-46 years old) were tested with natural pupils, and then retested after stable pupillary dilation with neutral density filters of 0.0, 0.6, 1.2, and 1.6 log unit in front of the subject's eye. Study 2, predicting effect of reduced illuminance: 17 eyes of 17 subjects (26-61 years old) were tested with natural pupils, and then retested after stable pupillary miosis (assessed with an infrared camera). A quantitative adaptation model was fit to results of Study 1; the mean adaptation parameter was used to predict change in Study 2.
RESULTS: Study 1: Mean defect (MD) decreased by 10 dB over a 1.6 log unit range of retinal illuminances; model fits for all subjects had r2> 95%. Study 2: Change in MD (DeltaMD) ranged from -7.3 dB to +0.8 dB. The mean adaptation parameter from Study 1 accounted for 69% of the variance in DeltaMD (P <0.0005), and accuracy of the model was independent of the magnitude of DeltaMD (r2< 1%, P >0.75).
CONCLUSIONS: The results confirmed previous findings that FDT perimetry can be dramatically affected by variations in retinal illuminance. Application of a quantitative adaptation model provided guidelines for estimating effects of pupil diameter and lens density on FDT perimetry.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15623778     DOI: 10.1167/iovs.04-0264

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  8 in total

1.  Assessing spatial and temporal properties of perimetric stimuli for resistance to clinical variations in retinal illumination.

Authors:  William H Swanson; Mitchell W Dul; Douglas G Horner; Tiffany Liu; Irene Tran
Journal:  Invest Ophthalmol Vis Sci       Date:  2014-01-20       Impact factor: 4.799

2.  Frequency doubling technology and standard automated perimetry in detection of glaucoma among glaucoma suspects.

Authors:  Sagarika Patyal; Atul Kotwal; Ajay Banarji; V S Gurunadh
Journal:  Med J Armed Forces India       Date:  2014-10-25

3.  Novel electrophysiological instrument for rapid and objective assessment of magnocellular deficits associated with glaucoma.

Authors:  Vance Zemon; James C Tsai; Max Forbes; Lama A Al-Aswad; Chi-Ming Chen; James Gordon; Vivienne C Greenstein; George Hu; Evy C Strugstad; Elona Dhrami-Gavazi; Lawrence F Jindra
Journal:  Doc Ophthalmol       Date:  2008-05-16       Impact factor: 2.379

4.  Development and evaluation of a contrast sensitivity perimetry test for patients with glaucoma.

Authors:  Aliya Hot; Mitchell W Dul; William H Swanson
Journal:  Invest Ophthalmol Vis Sci       Date:  2008-03-31       Impact factor: 4.799

5.  Choice of Stimulus Range and Size Can Reduce Test-Retest Variability in Glaucomatous Visual Field Defects.

Authors:  William H Swanson; Douglas G Horner; Mitchell W Dul; Victor E Malinovsky
Journal:  Transl Vis Sci Technol       Date:  2014-09-25       Impact factor: 3.283

6.  Optimizing contrast sensitivity perimetry for clinical use.

Authors:  Mitchell W Dul
Journal:  J Ophthalmic Vis Res       Date:  2013-01

7.  Contrast sensitivity perimetry and clinical measures of glaucomatous damage.

Authors:  William H Swanson; Victor E Malinovsky; Mitchell W Dul; Rizwan Malik; Julie K Torbit; Bradley M Sutton; Douglas G Horner
Journal:  Optom Vis Sci       Date:  2014-11       Impact factor: 1.973

8.  Comparison of Humphrey MATRIX and Swedish interactive threshold algorithm standard strategy in detecting early glaucomatous visual field loss.

Authors:  Raju Prema; Ronnie George; Arvind Hemamalini; Ramesh Sathyamangalam Ve; Mani Baskaran; Lingam Vijaya
Journal:  Indian J Ophthalmol       Date:  2009 May-Jun       Impact factor: 1.848

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.